Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ELIDEL | Bausch Health Companies | N-021302 RX | 2001-12-13 | 1 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
atopic dermatitis | EFO_0000274 | D003876 | L20 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 3 | 3 | 8 | 25 | 7 | 46 |
Oral lichen planus | D017676 | — | — | — | 2 | 1 | 1 | — | 4 |
Eczema | D004485 | HP_0000964 | L30.9 | — | — | — | 1 | — | 1 |
Vitiligo | D014820 | EFO_0004208 | L80 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Coronary disease | D003327 | — | — | — | — | 2 | — | — | 2 |
Perioral dermatitis | D019557 | EFO_1001305 | L71.0 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Exanthema | D005076 | HP_0000988 | — | — | 1 | — | — | — | 1 |
Prurigo | D011536 | — | L28.2 | — | 1 | — | — | — | 1 |
Seborrheic dermatitis | D012628 | HP_0001051 | L21 | — | 1 | — | — | — | 1 |
Lichen sclerosus et atrophicus | D018459 | — | L90.0 | — | 1 | — | — | — | 1 |
Netherton syndrome | D056770 | — | — | 1 | 1 | — | — | — | 1 |
Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Discoid lupus erythematosus | D008179 | — | L93.0 | — | — | — | — | 2 | 2 |
Cutaneous lupus erythematosus | D008178 | EFO_0003834 | L93.1 | — | — | — | — | 1 | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 1 | 1 |
Drug common name | Pimecrolimus |
INN | pimecrolimus |
Description | Pimecrolimus is an immunosuppressant drug of the calcineurin inhibitor class used in the treatment of atopic dermatitis (eczema). It is available as a topical cream, once marketed by Novartis (however, Galderma has been promoting the compound in Canada since early 2007) under the trade name Elidel.
|
Classification | Small molecule |
Drug class | immunosuppressives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC |
PDB | — |
CAS-ID | 137071-32-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1200686 |
ChEBI ID | — |
PubChem CID | 16051947 |
DrugBank | DB00337 |
UNII ID | 7KYV510875 (ChemIDplus, GSRS) |